Top Banner
© FIND/Jaqured Debayle Stakeholders Roundtable on DST diagnostic technologies Geneva, March 29 th
14

Future Hain Products

Jan 23, 2018

Download

Documents

John Rice
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Future Hain Products

© F

IND

/Jaqure

d D

ebayle

Stakeholders Roundtable

on DST diagnostic

technologies

Geneva, March 29th

Page 2: Future Hain Products

Hain Lifescience | The present

»Our products in TB

diagnostics are used

worldwide«

Efficient TB-screening

with FluoroType MTB

MDR-TB testing with

GenoType MTBDRplus

Further XDR-TB testing with GenoType MTBDRsl

And much more

Page 3: Future Hain Products

Hain Lifescience | The present

FluoroType MTB »The innovative screening test for every lab«

Fast results

Manual or automated DNA extraction

possible

Extraction control ensures valid results

Step-wise diagnostics for MDR- and XDR-TB

is possible using the same DNA isolate

Page 4: Future Hain Products

Hain Lifescience | The present

GenoType MTBDRplus VER 2.0 »The globally established test for MDR-TB«

Page 5: Future Hain Products

Hain Lifescience | The present

Now available: GenoType MTBDRsl VER 2.0

Increased sensitivity for Kanamycin and

Fluoroquinolones

Sample Material: smear-negative and -positive

specimens

DNA Polymerase: included in ready-to-use

amplification mix

GenoType MTBDRsl »PCR test for XDR-TB«

Page 6: Future Hain Products

TB in Germany

»TB incidence in Germany | The past«

• TB incidence was high in

Germany

• Microscopy and other

diagnostics was performed by

many labs

Year Incidence rate /10,000

1940 156,8

1950 277

1960 126,6

1970 79,3

Page 7: Future Hain Products

TB in Germany

»TB incidence in Germany | Today«

• Today only a few labs are involved in TB diagnostics

• Specialised labs are located in hospitals and medium to large

private or public lab units

• The combination of specialised labs and hospital enables a

efficient diagnostics and prompt therapy

Year Incidence rate /10,000

2010 5,4

2013 5,3

Page 8: Future Hain Products

The Future

The lab of the future

Page 9: Future Hain Products

The Future

»Future labs«

Decentralised labs are struggling

to keep pace with the development

of new infrastructure

Centralised and specialised

labs connected to a hospital

can help to fight today‘s TB

problems

Page 10: Future Hain Products

The Future

»Reliable partners for the lab of the future«

Offering solutions including a complete system from DNA isolation

to reliable result

Page 11: Future Hain Products

The Future

»FluoroType MTBDR«

• Proprietary innovative

technology: LATE PCR

followed by a

LightON/LightOFF detection

• For small medium and high

throughput: Manual extraction

or fully automated solution

• Fast results: Reliable results within 3 hours

• True MDR-TB testing: Detection of Rifampicin and Isoniazid

resistance

• One stop shop: Everything is available from sole supplier

Page 12: Future Hain Products

The Future

»Reliable TB diagnostics for low to high throughput«

Page 13: Future Hain Products

The Future

Pyrazinamide

NTM

NTM drug resistance

...

XDR-TB

»Upcoming test systems«

Our upcoming assays enables a

complete routine diagnostics based

on a single system

HBV viral load

Norovirus

HPV

HIV viral load

Sepsis

Enteric panel

Human genetics

...

STI panel

Influenza

Page 14: Future Hain Products

© F

IND

/Jaqure

d D

ebayle

Thank you for your

attention!